BioQuakes

AP Biology class blog for discussing current research in Biology

Tag: cancer treatment research

Preserve Biodiversity & Save Lives

How elephants are crucial to cancer research

Over the course of the past few years intensive research has been done on elephants specifically on studying their cells. Elephant’s cells can play an extensive role in advancing cancer research for humans. You may be wondering why is this? How is an elephant’s cell so unique? Well elephants rarely get cancer. This may seem impossible since they weigh tons which means their cells are significantly bigger than a human sized cell, and they should be more prone to getting cancer. In addition, elephants have “hundreds of times the number of cells — and have similarly long natural lifespans — but their cells mutate, become cancerous, and kill them less frequently”. This peculiar trait is being studied by the ACE team, they have given it the name ‘Peto’s Paradox’ named for Richard Peto, a British epidemiologist.” Elephants make multiple copies of their genes, so if a mutation does occur in an elephant’s cell thus becoming cancerous “..instead of reproducing, just kill themselves.”

Researchers now are trying to work with human cells and see if this “cancer-fighting technique” used by elephants could lead to new medical treatments. Peto’s Paradox seems to work on every type of cancer that it was tried on. Which would really cut down on the time and money needed to study every form/type of cancer. If  Peto’s Paradox were to work on human cells on a bigger scale than just the “petri dish” used in this study more time could be devoted to just perfecting this technique in human cells and would for the first time ever be a revolutionary cure for every cancer known to man.  

Protecting Elephants

According to research African forest elephants help fight against climate change. There is a direct correlation between African forest elephant eating patterns and a reduction in carbon emissions released in their ecosystem. “African forest elephants need to eat 5-10 percent of their body weight (about 200-600 pounds) every day. They mostly feed on trees with lower wood density — leaving more room in the forest for the growth of high-wood-density trees that more efficiently absorb carbon in the environment, reported Ahimsa Campos-Arceiz from University of Nottingham.” Sadly, this species faces constant threats from poachers and the ever rising issue of deforestation. It’s essential to protect elephants and their habitats so they don’t go extinct. “[I]f African forest elephants go extinct, above-ground biomass — the organic materials such as trees that live above soil, essential to storing carbon — would decrease by 7 percent in Central Africa’s rainforests. Tropical forests can provide at least 30 percent of the mitigation needed to limit global warming, making their protection vital not only for the elephants’ diets and habitats, but for the planet.”

As mentioned earlier elephants rarely get cancer so if their species die off, so would the key to finding a cure for cancer in humans as many leading scientists believe. Elephants are virtually on the edge of extinction, their disappearance could have far-reaching effects for both public health and cancer research. As a result, scientists are trying to quickly gather as much data as they can while elephants are still here. However not all hope is lost. Conservation International is working hard to protect species such as elephants, the habitat they live in, and to help stabilize climates all around the world.

New Understanding in Telomerase Structure: Can It Lead to New Cancer Treatment Medications?

Telomerase. They know what it is. They know what it does. They know it is involved with the formation of malignant tumors. Yet for years, cancer researchers could not figure out a way to curb telomerase activity. Not until recently, when a group of researchers at the University of California, Santa Cruz discovered an important structural component of telomerase that could lead to the development of new and more efficient cancer treatment medications.

But first things first: what even is telomerase? To understand the role of telomerase, we must first understand what a telomere is. Analogous to the “plastic tips of shoelaces”, telomeres are located at the tips of chromosomes to keep the ends of DNA from “fraying”, consisting of the repetition of the same nitrogenous base sequence over and over again. In humans, this base sequence is TTAGGG.

Screen Shot 2015-10-05 at 7.44.26 PM(Source: https://en.wikipedia.org/wiki/Telomere#/media/File:Telomere.png)

The sequence can be up to 15,000 base pairs long; however, each time a cell divides, the telomeres get shorter and shorter until they become they become too small to divide again. That is when the telomerase comes in; it adds nucelotides to the telomere to prevent it from becoming senescent, or at least prolong the cell’s life span.

Sounds like a good thing, right? Not when the telomerase gets out of control and does not allow for cells to die, causing a huge growth of cells that eventually evolve into malignant tumors.

What makes it hard for scientists to combat excessive telomerase activity is due to the enzyme’s unique and complex structure. In addition to its sophisticated quaternary structure, telomerase also has an RNA template that allows the telomerase to make the DNA bases (TTAGGG) for the telomere.

Screen Shot 2015-10-05 at 10.24.26 PM

(Source: https://vi.wikipedia.org/wiki/Telomerase#/media/File:Telomerase_illustration.jpg)

Researchers at UC Santa Cruz determined the structure of the RNA binding domain of telomerase and how the template border is dependent on how the protein and RNA components interact with each other. Understanding this interaction can help scientists develop cancer medications that more specifically inhibit telomerase. This is the first major advancement in telomerase research since November of 2010 when biochemists at UCLA created an unprecedented 3D model of telomerase’s RNA structure.

While this discovery is a major step forward in cancer treatment research,  some experts have their reservations against finding methods of inhibiting telomerase altogether.

However, regardless of the controversy surrounding telomerase inhibition in cancer treatment, this discovery will be useful in coming up with tactics to prevent aging, and improve treatments in other medical fields, such as burns, bone marrow transplants, and heart disease.

What do you think? Leave a comment below!

 

 

Original Article

New Information on DNA Repair Could Mean Better Cancer Treatments

Photo Taken by EMW http://en.wikipedia.org/wiki/File:Protein_BRCA1_PDB_1jm7.png

Photo Taken by EMW http://en.wikipedia.org/wiki/File:Protein_BRCA1_PDB_1jm7.png

 

It has been accepted that DNA repairs itself.  However, a discovery concerning how this process occurs could lead to more efficient, and thus less damaging, cancer treatments.  Medical researchers at the University of Alberta have expanded the knowledge that scientists have regarding two proteins: BRCA1 (shown in the image) and TopBP1.  These proteins were previously thought to play identical roles in the DNA repair process.  However, this team of researchers recently showed that BCRA1 searches for any damaged DNA and then signals for help, while TopBP1 searches for DNA damaged specifically due to a problem with the DNA replication process and then signals for help.

Cancer Treatment Improvements?

When DNA becomes too damaged, cancer results.  The new cancer DNA can then copy itself and spread.  New ideas concerning radiation therapy making the cancer DNA unable to repair itself and unable to replicate are arising with this new discovery about the DNA-repairing proteins’ roles.  For instance, once cancer cells are damaged, proteins try to fix them, renewing the cancer cells.  Treatment could potentially be targeted at these proteins to stop them from fixing the cancer DNA and allowing the replication process to continue, now that we more fully understand their functions.

I find it fascinating to see how a rather basic discovery can have such major outcomes, and I am curious to see if further research will determine if certain medication can affect these powerful proteins.  Are there any other potential benefits to this protein-related discovery?

 

Original Article

For more information about DNA damage and repair and the role of the TopBP1 protein, click here. (Section 4 on this link talks about the similarities between BRCA1 and TopBP1.)

 

 

 

Powered by WordPress & Theme by Anders Norén

Skip to toolbar